Hints and tips:
Related Special Reports
Related Topics
Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after they opposed CEO pay package
GQG Partners argues that pharma group has performed strongly under long-serving chief
Shareholder advisory groups say potential £18.7mn payout is excessive
Drugmaker releases promising trial results for a pill and expects to enter China this year
WuXi AppTec and WuXi Biologics under threat from proposed national security legislation
Report from Nuffield Trust health think-tank highlights impact of leaving EU on medicine supply chains
Xylazine, commonly used to sedate animals, found cut with heroin, counterfeit tablets and cannabis vapes, study finds
Record shortages of common drugs have countries scrambling for alternatives while patients skip treatments
Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss
Danish group seeks to branch out from diabetes and weight loss drugs with Cardior acquisition
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Acquisition gives pharmaceutical group mid-stage asset to challenge Novartis in new form of cancer care
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
Nice fails to approve Enhertu due to value-for-money concerns despite it being recommended in Scotland
Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases
Annual earnings at Anglo-Swedish pharma group miss expectations but revenues rise to $45.8bn
Research shows urgent need for policies to encourage weight loss and cut disease risk
International Edition